University Of Texas/Texas Am Investment Management Co's Form 4 filing
Rein Therapeutics, Inc. (RNTX) · filed Jun 17, 2024
- Accession no.
- 0001019231-24-000026
- Filed
- Jun 17, 2024
- Trade date
- Jun 14-17, 2024
- Filing delay
- 3 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions. Open-market sales total $21.6K. It was filed 3 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| University Of Texas/Texas Am Investment Management CoCIK 0001019231 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 14, 2024 | Common Stock | SSaleDisposed | −1,900 | $3.30 | −$6,270 | 1,751,256 | Direct | |
| Jun 17, 2024 | Common Stock | SSaleDisposed | −4,707 | $3.25 | −$15,297.75 | 1,746,549 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.